A 62-year-old Asian-American female arrives at your office for a new patient appointment. Her current medications are metformin, pioglitazone, enalapril, lovastatin, alendronate, calcium supplements and vitamin D. Her A1C is on target at 6.9%, however you decide to replace her pioglitazone with a different antihyperglycemic medication. Why would you make this decision? A. Pioglitazone increases the risk of hypertriglyceridemia B. Pioglitazone increases the risk for cardiovascular events C. Pioglitazone increases the risk for fractures D. Pioglitazone increases the risk for hypoglycemia Follow the link to see the right answer.
Read More »Yearly Archives: 2017
SGLT-2 as 2nd Drug
Are you open to recommending an SGLT-2 inhibitor as a second drug for a patient with type 2 diabetes who is overweight and has not met their goal? Follow the link to see how you compare to your colleagues.
Read More »OptiScanner
OptiScanner is the first-of-its-kind bedside blood monitoring platform that provides plasma-based, automated monitoring of ICU patients’ glucose levels. The OptiScanner 5000 directly measures plasma glucose levels using an integrated blood centrifuge and spectrometer to help avoid dangerous glycemic variations and assist clinicians in achieving the right level of glucose control.
Read More »R. Keith Campbell Recognized with Lifetime Achievement Award
Pharmacy innovator Keith Campbell, B.Pharm, MBA, CDE, who sits on our board of advisors at Diabetes in Control, is one of the first pharmacists to become a certified diabetes educator and the inspiration for hundreds of other pharmacists and nurses who since followed in his footsteps, received the Lifetime Achievement Award on Friday, Oct. 20, 2017 at the Washington State University College of Pharmacy Crimson Gala.
Read More »Sheri Colberg Current Interview
Sheri R. Colberg, PhD, FACSM is Professor Emerita of Exercise Science from Old Dominion University and an internationally recognized authority on diabetes and exercise. She is the author of 11 books, 24 book chapters, and over 300 articles. The author of "Exercise and Diabetes: A Clinician's Guide to Prescribing Physical Activity," published by ADA in 2013, she is also the lead author on a new ADA position statement on physical activity and diabetes published last fall. In 2016, she received the ADA Outstanding Educator in Diabetes Award.
Read More »Sheri Colberg Transcript
Sheri Colberg discusses her work as a diabetes educator and author, and the challenges and benefits of exercising with diabetes.
Read More »Sheri Colberg Full Interview
In this Exclusive Interview, Sheri Colberg talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California about the necessity and even ease of working physical activity into everyday life, the necessary and best types of exercise, and its possible impact on most people.
Read More »Sheri Colberg Part 1, Exercise and Being Active with Diabetes
In part 1 of this Exclusive Interview, Sheri Colberg talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California about the recent exercise position statement presented at ADA.
Read More »Sheri Colberg Part 2, New Position on Exercise and Diabetes
In part 2 of this Exclusive Interview, Sheri Colberg talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California about the types of exercise that are good for everyone.
Read More »Sheri Colberg Part 3, Balance Exercises for Diabetics
In part 3 of this Exclusive Interview, Sheri Colberg shares some atypical balance exercises with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California about.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.